Y. Oka

发表

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

M. Hino, S. Kishida, N. Hosen, 2012, Leukemia.

Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product1

K. Aozasa, A. Tsuboi, Y. Oka, 2000, The Journal of Immunology.

The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

M. Tomonaga, K. Aozasa, Kazushi Inoue, 1999, Leukemia.

Wilms' tumour gene 1 (WT1) in human neoplasia

C. Scheibenbogen, Y. Oji, Y. Oka, 2005, Leukemia.

Efficient Induction of Peptide‐Specific Cytotoxic T Lymphocytes by LPS‐Activated Spleen Cells

K. Nakashima, Y. Oka, H. Sugiyama, 2000, Microbiology and immunology.

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.

Y. Sonoda, Y. Oji, H. Tamaki, 1997, Blood.

Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.

A. Hakura, H. Sugiyama, H. Inoue, 1989, The Journal of general virology.

Rearrangement of immunoglobulin heavy chain genes and T3 expression in the absence of rearrangement of T-cell receptor beta-chain gene in a patient with T-cell malignant lymphoma.

T. Komori, T. Soma, H. Ogawa, 1986, Leukemia research.

Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies

I. Kawase, N. Hosen, Y. Oji, 2005, Leukemia.

Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells.

Y. Oji, H. Tamaki, M. Kawakami, 1998, Blood.

Cyclic regulation of B220 antigen expression in immature B cell lines

H. Sugiyama, Y. Oka, Y. Shimizu, 1994, Immunology and cell biology.

A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice.

I. Kawase, M. Kawakami, T. Soma, 2006, Cytotherapy.

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

T. Kyo, N. Hosen, Y. Oji, 2012, Leukemia.

Regulation of Thy-1 gene expression by the methylation of the 5' region of Thy-1 gene and intracellular regulatory factors in immature B cells.

H. Ogawa, H. Sugiyama, T. Kishimoto, 1992, Immunological Investigations.

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

H. Sugiyama, Y. Oji, H. Tamaki, 2000, Immunogenetics.

Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities

E. Morii, N. Hosen, Y. Oji, 2016, Oncogene.

Expression of the interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia.

H. Ogawa, H. Sugiyama, Y. Oka, 1994, Blood.

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38− cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells

I. Kawase, N. Hosen, Y. Sonoda, 2004, Leukemia.

WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission

N. Hosen, Y. Oji, A. Tsuboi, 2012, Leukemia.

Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin

I. Kawase, N. Hosen, Y. Oji, 2003, Bone Marrow Transplantation.

Selective use of the VHQ52 family in functional VH to DJH rearrangements in a B precursor cell line

T. Komori, T. Soma, H. Ogawa, 1987, The Journal of experimental medicine.

The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links.

H. Sugiyama, Y. Oka, T. Nomura, 1993, Mutation research.

The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis

I. Weissman, M. Okabe, N. Hosen, 2007, Leukemia.

In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity

N. Hosen, Y. Oji, A. Tsuboi, 2014, Leukemia.

Differentiation of an Abelson virus-transformed immature B precursor cell line under the expression of tyrosine kinase activity of v-abl oncogene product.

T. Komori, A. Hakura, Y. Oka, 1987, Cell differentiation.

Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway

M. Asada, Y. Tsujimoto, S. Shimizu, 2006, Oncogene.

Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

Y. Oji, H. Tamaki, M. Kawakami, 1999, Leukemia research.

Transitory expression of Thy-1 antigen in immature B cell lines.

Y. Oka, H. Sugiyama, Y. Oka, 1992, Immunological investigations.

Unlinked regulation of cell growth and differentiation in immature B cell lines.

A. Hakura, H. Sugiyama, H. Inoue, 1990, Cellular immunology.

Immature B cells can pass through a VHDJH/germ line state in the Ig H chain gene rearrangements.

H. Sugiyama, Y. Oka, S. Kishimoto, 1990, Journal of immunology.

Estimation of D segment usage in initial D to JH joinings in a murine immature B cell line. Preferential usage of DFL16.1, the most 5' D segment and DQ52, the most JH-proximal D segment.

H. Sugiyama, Y. Oka, S. Kishimoto, 1990, Journal of immunology.

Suppression of Wilms' tumor gene (WT1) expression induces G2/M arrest in leukemic cells.

Y. Oji, H. Tamaki, A. Tsuboi, 1998, Leukemia research.

Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia.

K. Aozasa, Y. Oji, H. Tamaki, 1996, Blood.

Identification of a Wilms’ tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes

Z. Berneman, Y. Oji, H. Sugiyama, 2013, Leukemia.

Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers.

S. Miyoshi, I. Kawase, H. Hirabayashi, 2004, Neoplasma.